AIM - AIM ImmunoTech Inc.
0.0949
-0.023 -24.025%
Share volume: 2,305,517
Last Updated: 04-04-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$0.12
-0.02
-0.19%
View ratios
Fiscal Date | 12-31-2024 | |
---|---|---|
Fiscal Quarter | Q4 2024 | |
Report Date | 03-27-2025 | |
Total revenue | 45.000 K | |
Cost of revenue | 0.000 | |
Gross profit | 45.000 K | |
Operating expenses | 5.893 M | |
Selling general and admin | 4.229 M | |
Research and development | 1.664 M | |
Total expenses | 5.900 M | |
Operating income | -5.855 M | |
Ebit | -5.936 M | |
Pretax income | -6.257 M | |
Income tax | 0.000 | |
Net income basic | 0.000 | |
Net income | -5.967 M | |